Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
adjuvanted placebo
BIOLOGICAL
2 trials
Sponsors
PepTcell Limited
Conditions
Influenza
Phase 2
A Randomised, Double-blind, Placebo-controlled Phase IIb Trial to Test FLU-v Vaccine
Completed
NCT02962908
PepTcell Limited
Influenza
Start: 2016-08-31
End: 2017-07-18
Updated: 2020-09-16
Efficacy of FLU-v in an H1N1 Influenza Human Challenge Model
Completed
NCT03180801
PepTcell Limited
Influenza
Start: 2016-08-18
End: 2017-05-25
Updated: 2020-08-05
Related Papers
Immunogenicity, Safety, and Efficacy of a Standalone Universal Influenza Vaccine, FLU-v, in Healthy Adults: A Randomized Clinical Trial.
2020-03-10
27 citations
Evaluation of the immunogenicity and safety of different doses and formulations of a broad spectrum influenza vaccine (FLU-v) developed by SEEK: study protocol for a single-center, randomized, double-blind and placebo-controlled clinical phase IIb trial.
2017-04-04
28 citations